Literature DB >> 17620522

Neurogenic abnormalities in masked hypertension.

Guido Grassi1, Gino Seravalle, Fosca Quarti Trevano, Raffaella Dell'oro, Gianbattista Bolla, Cesare Cuspidi, Francesca Arenare, Giuseppe Mancia.   

Abstract

Patients with hypertension exhibit an increased sympathetic activity. No information exists as to whether this is the case in normotensive individuals in whom there is an increased ambulatory blood pressure, a condition termed "masked" hypertension. We studied 18 middle-aged subjects with masked hypertension in whom we measured muscle sympathetic nerve traffic (peroneal nerve and microneurography) and beat-to-beat arterial blood pressure at rest and during baroreceptor deactivation and activation. Measurements also included anthropometric values and insulin sensitivity (homeostasis model assessment index). Data were compared with those of 20 normotensive subjects, 18 subjects with white-coat hypertension, and 20 patients with "in-office" and "out-of-office" hypertension. All of the individuals were pharmacologically untreated and age-matched with subjects with masked hypertension. Patients with in- and out-of-office and white-coat hypertension displayed resting sympathetic nerve activity values significantly greater than normotensive subjects (75.8+/-2.5 and 70.8+/-2.2 versus 45.5+/-2.0 bursts per 100 heartbeats respectively; P<0.01). This was the case also for masked hypertension (73.5+/-2.4 bursts per 100 heartbeats; P<0.01), the degree of the sympathetic activation being similar for magnitude to that seen in the other 2 hypertensive conditions. Compared with normotensive subjects, baroreflex-heart rate control was significantly attenuated in all of the hypertensive states, whereas baroreflex-sympathetic control was unaffected. Homeostasis model assessment index was increased in patients with in- and out-of-office and white-coat hypertension, with a further increase in masked hypertension and a direct relation with resting sympathetic nerve traffic (r=0.46; P<0.01). These data provide the first evidence that masked hypertension is characterized by a marked sympathetic overdrive. They further show that the neurogenic alterations are coupled with metabolic and baroreflex abnormalities.

Entities:  

Mesh:

Year:  2007        PMID: 17620522     DOI: 10.1161/HYPERTENSIONAHA.107.092528

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  31 in total

1.  Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension.

Authors:  Mohammed Siddiqui; Eric K Judd; Byron C Jaeger; Hemal Bhatt; Tanja Dudenbostel; Bin Zhang; Lloyd J Edwards; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

Review 2.  Autonomic nervous system dysregulation in pediatric hypertension.

Authors:  Janusz Feber; Marcel Ruzicka; Pavel Geier; Mieczyslaw Litwin
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

3.  Metabolic risk factors and masked hypertension in the general population: the Finn-Home study.

Authors:  M-Ra Hänninen; T J Niiranen; P J Puukka; A M Jula
Journal:  J Hum Hypertens       Date:  2014-01-02       Impact factor: 3.012

Review 4.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

5.  Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.

Authors:  Mohammed Siddiqui; Eric K Judd; Tanja Dudenbostel; Bin Zhang; Pankaj Gupta; Maciej Tomaszewski; Prashanth Patel; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2019-07-22       Impact factor: 10.190

6.  Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study.

Authors:  Paul E Drawz; Roland Brown; Luca De Nicola; Naohiko Fujii; Francis B Gabbai; Jennifer Gassman; Jiang He; Satoshi Iimuro; James Lash; Roberto Minutolo; Robert A Phillips; Kyle Rudser; Luis Ruilope; Susan Steigerwalt; Raymond R Townsend; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-05       Impact factor: 8.237

Review 7.  Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension.

Authors:  Jasenka Zubcevic; Hidefumi Waki; Mohan K Raizada; Julian F R Paton
Journal:  Hypertension       Date:  2011-05-02       Impact factor: 10.190

Review 8.  The complexity of masked hypertension: diagnostic and management challenges.

Authors:  Stanley S Franklin; Nathan D Wong
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 9.  Sympathetic neural mechanisms in human hypertension.

Authors:  Ronald G Victor; Moiz M Shafiq
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

Review 10.  White-coat hypertension should not be treated in subjects with diabetes.

Authors:  Michael Bursztyn; Iddo Z Ben-Dov
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.